Delivery Order SPE2DB22D3501-SPE2DB26FTK23
Award Date 11/5/25
Potential Completion Date 11/28/25
Potential Value $8.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Tecentriq 840 mg/14 ml vials. This $4,252.30 delivery order, which carries a firm fixed price contract type with no set-aside designation, is scheduled for completion by November 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. Tecentriq is a specialized pharmaceutical product used in oncology treatment, reflecting the critical role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,504.62 on September 19, 2025, for the supply of Tecentriq 840 mg/14 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of October 10, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. The contract represents a non-set-aside award made through open competition, reflecting AmerisourceBergen's demonstrated capability to fulfill...
- The Defense Logistics Agency awarded a $17,009.24 delivery order to AmerisourceBergen Drug Corp for Tecentriq 840 mg/14 ml vials on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major distribution hub for federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,252.30 to AmerisourceBergen Drug Corp for the supply of Tecentriq 840 mg/14 mL vials on November 5, 2025. This competitively awarded, firm fixed-price delivery order is set to conclude by November 28, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $17,009.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Tecentriq (atezolizumab) 840 mg/14 mL vials on May 19, 2025, with completion targeted for June 10, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a $999,999,999 ceiling and runs through December 2026. The pharmaceutical distributor is...
- The Defense Logistics Agency awarded a delivery order valued at $17,009.24 to AmerisourceBergen Drug Corp for the supply of Tecentriq 840 mg/14 ml vials. This firm fixed-price, competitively awarded contract was issued on August 12, 2025, with an ultimate completion date of September 3, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside acquisition, this delivery order was open to competition among qualified...
- The Defense Logistics Agency awarded a $8,504.62 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Tecentriq (atezolizumab) 840 mg/14 mL vials. This competitively awarded, firm fixed-price contract is scheduled for completion by May 15, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award carries no set-aside designation, reflecting the vendor's capability to compete successfully in open procurement processes for federal...
- The Defense Logistics Agency awarded a $25,189 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tecentriq Hybridza 1,875 mg 15 ml pharmaceutical product. This is a non-set-aside competitive award with an ultimate completion date of September 30, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate...
- This federal contract award, valued at $17,009.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty medication, to support military healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, to provide the specialty medication Tecentriq (840 mg/14 ml vial) under a firm fixed price delivery order. The award has a ceiling value of $16,032.60 and a period of performance through April 4, 2024. AmerisourceBergen Drug Corp is the prime contractor for this award, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up...